NCT04981041: Escalated Single Platelet Inhibition for One Month Plus NOAC in Patients With Atrial Fibrillation and ACS Undergoing PCI
- State
- Completed
- Phase
- Phase 4
- People
- 602 taking part
- Started
- 16 Dec 2021
- Primary completion
- 22 May 2026
- Arms
- Potent P2Y12-Inhibition
- Results
- None posted
- 28 Jul 2021: Trial registered
- 16 Dec 2021: Trial started
- 30 May 2026: Trial completed